Variant report
Variant | esv3525400 |
---|---|
Chromosome Location | chr4:86564261-86564759 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147804106 | chr4:86564281-86564282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577691525 | chr4:86564292-86564293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35477084 | chr4:86564316-86564317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112038990 | chr4:86564323-86564324 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs151056596 | chr4:86564364-86564365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76227113 | chr4:86564367-86564368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76955229 | chr4:86564370-86564371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs13137331 | chr4:86564386-86564387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs61182606 | chr4:86564388-86564389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs201972323 | chr4:86564389-86564390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561040484 | chr4:86564408-86564409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs70948741 | chr4:86564413-86564414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559907427 | chr4:86564497-86564498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs60134716 | chr4:86564537-86564538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543347162 | chr4:86564542-86564543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs59477193 | chr4:86564560-86564561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531933951 | chr4:86564568-86564569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550432424 | chr4:86564608-86564609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567315419 | chr4:86564613-86564614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571693678 | chr4:86564630-86564631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183155685 | chr4:86564702-86564703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547738597 | chr4:86564707-86564708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565952445 | chr4:86564709-86564710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536291246 | chr4:86564710-86564711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12503569 | chr4:86564716-86564717 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Prostate cancer | 16573809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:86551400-86575200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr4:86551800-86569600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr4:86559600-86576600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
4 | chr4:86559800-86580200 | Weak transcription | Fetal Muscle Leg | muscle |
5 | chr4:86560000-86565000 | Weak transcription | Ovary | ovary |
6 | chr4:86560000-86565400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr4:86561800-86582800 | Weak transcription | K562 | blood |
8 | chr4:86562400-86579000 | Weak transcription | Right Ventricle | heart |
9 | chr4:86562800-86564400 | Enhancers | GM12878-XiMat | blood |
10 | chr4:86563200-86570200 | Weak transcription | Primary B cells from cord blood | blood |
11 | chr4:86563800-86564400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
12 | chr4:86564000-86574400 | Weak transcription | Primary B cells from peripheral blood | blood |
13 | chr4:86564400-86564800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |